Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06535139 · ClinicalTrials.gov registry record · NA

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

A NA study of Papillomavirus Vaccines, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
4,630
Enrollment target
1
Study location

NCT06535139: Recruiting NA study of Papillomavirus Vaccines, sponsored by University of Florida.

NCT06535139 is a NA study of Papillomavirus Vaccines that is actively recruiting participants, run by University of Florida. The registered enrollment target is 4,630 participants, above the 2,754-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06535139, a NA study of Papillomavirus Vaccines, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
4,630 participants
Enrollment target
1
Study location

Study Summary

There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with community-targeted healthcare access assistance beyond the effects of clinician-targeted training. Second, we will estimate the differential effectiveness of the implementation strategies by patient-level factors (age, race/ethnicity, sex, distance from home to clinic, social vulnerability). Third, we will measure moderation of implementation strategy effectiveness by clinic-level factors (HPV vaccination priority, resources, clinic visit types, scheduling practices, and implementation success). Within 11 rural North Central Florida counties, we will evaluate the layering of evidence-based implementation strategies that progressively addressing clinician, parent, and healthcare access barriers faced by rural communities on HPV vaccination rates among 9- to 12-year-olds. To best address our main question of whether layering complementary strategies continues to increase effects on HPV vaccination, we will test our hypotheses with a three-arm cluster randomized study design of nested strategies. The proposed nested study design optimizes evaluation, causal inference, and scientific rigor by putting the maximum number of clinics towards addressing the layering of strategies. Randomization will occur at the clinic level. All clinics will receive implementation strategy A: clinician-targeted recommendation training. A random 20 of 30 of clinics will also receive facilitation of parent-targeted motivational aids (B) for an implementation strategy package of A+B. Finally, a random half of the clinics who receive A+B will also receive community-targeted healthcare access (C) for a total implementation strategy package of A+B+C. This equates to a three-arm cluster randomized trial in which 10 clinics receive clinician- targeted recommendation training alone

Primary Outcome

Binary measure at the participant level of receipt of one or more does of the HPV vaccine

Conditions Studied

Interventions

  • BEHAVIORAL Brief training
  • BEHAVIORAL Parent-targeted motivational aids
  • BEHAVIORAL Healthcare access

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 4,630 participants
Start Date 2024-12-09
Est. Completion 2027-07-01
Phase NA
University of Florida

1,106 total trials

What NCT06535139 shows while recruiting

NCT06535139 is an interventional study that assigns participants to a tested intervention. Its 4,630 participants enrollment target places it among the larger protocols in the corpus, above the 2,754-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (68% higher).

The record links to 1 condition, with Papillomavirus Vaccines appearing as the primary indexed condition, and to 3 interventions - of which Brief training is the first listed.

NCT06535139 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06535139 about?

NCT06535139 is a clinical study titled "ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention". There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with community-targeted healthcare access assistance beyond the effects of clinician-...

What is the current status of trial NCT06535139?

This trial is currently recruiting. It is a NA study. The enrollment target is 4,630 participants. The study started on 2024-12-09. Estimated completion is 2027-07-01.

What conditions does trial NCT06535139 study?

This clinical trial studies the following conditions: Papillomavirus Vaccines.

What interventions are being tested in trial NCT06535139?

The interventions under investigation include: Brief training (BEHAVIORAL), Parent-targeted motivational aids (BEHAVIORAL), Healthcare access (BEHAVIORAL).

Who is sponsoring clinical trial NCT06535139?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06535139 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Papillomavirus Vaccines

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05768217 · 4,600 participants · NA

    Community Resiliency Collective Efficacy Intervention

  • NCT04371900 · 4,700 participants · NA

    Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1

  • NCT05486572 · 4,700 participants · NA

    Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • NCT06888388 · 4,700 participants

    Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06535139, the US trial registry maintained by the National Library of Medicine. NCT06535139 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.